Fred Alger Management’s Ambrx Biopharma Inc AMAM Stock Holding History

Fred Alger Management’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-32,886	Closed	-$468K	–	505
2023 Q4	$468K	Buy	+32,886	New	+$374K	﹤0.01%	399

Fred Alger Management's AMAM Position: Q1 2024 in Review

Fred Alger Management sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 32,886 shares — an estimated $468K sold.

Fred Alger Management first reported a position in AMAM in Q4 2023 and held it in 1 quarter. The position peaked at $468K in Q4 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

Fred Alger Management reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
Fred Alger Management sold 32,886 Ambrx Biopharma Inc shares in Q1 2024, an estimated $468K.
Fred Alger Management first reported a position in Ambrx Biopharma Inc in Q4 2023 and held it in 1 quarter.
Fred Alger Management's Ambrx Biopharma Inc position peaked at $468K in Q4 2023.
0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on Fred Alger Management's 13F filing for Q1 2024, filed 15 May 2024.